Lydall Shares Climbing Higher, Up 1.3%

About a third of American adults have high LDL cholesterol — that's the bad kind — but less than half of adults with high LDL seek treatment, according to the Centers for Disease Control and Prevention. I smell an investment opportunity. ...

The app though costs R55, is a handy tool to keep track of your blood cholesterol, including LDL (bad) cholesterol and HDL (good) cholesterol. Just tell the app your LDL and HDL cholesterol whenever you have it.The app will keep the information

(Comtex SmarTrend(R)) Below are the three companies in the Industrial Machinery industry with the lowest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among companies in the same industry. ...

(GLOBE NEWSWIRE) -- Lydall, Inc. (NYSE:LDL) is pleased to announce that it will attend the Sidoti & Company, LLC Semi-Annual NY Micro Cap Conference at the Grand Hyatt Hotel in New York on June 7, 2013. Lydall management will give a 35-minute ...

Renowned lipidologist will discuss discordance in apoB and LDL-P study and interpretations for clinical practice PR Newswire RICHMOND, Va., May 22, 2013 /PRNewswire/ -- Dr. Thomas Dayspring, a Health Diagnostic Laboratory, Inc. Medical Advisory ...

Background: Plasma levels of small, dense low-density lipoprotein (LDL) were reported to increase in chronic kidney disease (CKD) patients on hemodialysis (HD), but most of these patients were hypertriglyceridemic. Plasma levels of small, dense LDL ...

Cardioviva supplement clinically proven to reduce LDL cholesterol, a risk factor in heart disease TORONTO, May 28, 2013 /CNW/ - Canadian innovation is at the heart of a new health supplement that offers a natural way to address high cholesterol, a ...

A new study published in the Journal of the American Society of Nephrology suggests that LDL cholesterol is not an effective marker in gauging the risk of heart disease in patients with kidney disease. High LDL cholesterol is a strong marker of heart disease ...

In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. Description of the Invention BACKGROUND Cardiovascular disease is one of ...